Condition: Retinitis Pigmentosa · Stargardt Macular Dystrophy · Stargardt Disease · Sponsor: Ray Therapeutics, Inc.
The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision. The mission of the VRAI is to enable the highest quality, standardized efficacy testing of patients with visual impairment. The VRAI facilitates the development and refinement of existing endpoints specifically for testing patients with Low Vision.
This description comes directly from the study's public registry record.
Reem Jaber, MS, CGC · 949-264-3793 · info@vr-ai.com
Always discuss trial participation with your own doctor first.
| Vision Research and Assessment Institute | Irvine, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07502664